Dermavant Sciences
Dermavant announces positive Phase III findings for psoriasis treatment tapinarof
February 19, 2021Medical Communications Dermavant Sciences, psoriasis
Dermavant Sciences has announced positive safety and efficacy results from a planned interim analysis of PSOARING 3, a long-term, open-label …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
